Sale!

DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the DLL3 gene responsible for spondylocostal dysostosis type 1. This advanced diagnostic test utilizes Next Generation Sequencing technology to detect autosomal recessive genetic variants causing vertebral and rib malformations. The test provides crucial information for families with history of skeletal abnormalities, enabling early intervention and personalized treatment planning. Available for $500 USD, this specialized genetic analysis offers precise detection of DLL3 gene mutations associated with congenital spinal deformities and thoracic cage abnormalities. Our genetic testing services include professional genetic counseling to help interpret results and guide family planning decisions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Spinal and Rib Abnormalities

The DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for spondylocostal dysostosis type 1. This rare genetic disorder affects spinal column development and rib formation, leading to significant skeletal abnormalities that can impact respiratory function and overall quality of life. Our advanced genetic testing provides definitive answers for families seeking clarity about inherited skeletal conditions.

What This Test Measures and Detects

This specialized genetic test utilizes Next Generation Sequencing (NGS) technology to comprehensively analyze the DLL3 gene for pathogenic variants associated with spondylocostal dysostosis type 1. The test specifically identifies:

  • Point mutations, deletions, and insertions in the DLL3 gene
  • Autosomal recessive inheritance patterns
  • Genetic variants affecting Notch signaling pathway
  • Mutations responsible for vertebral segmentation defects
  • Genetic causes of rib malformations and thoracic cage abnormalities

Who Should Consider This Genetic Test

This DLL3 gene test is recommended for individuals presenting with specific clinical indications:

  • Newborns or children with congenital spinal deformities
  • Patients with multiple vertebral segmentation defects
  • Individuals with rib abnormalities or thoracic cage malformations
  • Families with history of spondylocostal dysostosis
  • Couples with previous affected children planning future pregnancies
  • Patients with short trunk stature and respiratory complications
  • Individuals with abnormal spinal curvature detected in infancy

Clinical Benefits of Genetic Testing

Undergoing the DLL3 gene test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out spondylocostal dysostosis type 1
  • Family Planning Guidance: Enables informed reproductive decisions
  • Early Intervention: Facilitates timely medical and surgical management
  • Genetic Counseling: Provides comprehensive risk assessment for family members
  • Personalized Treatment: Guides appropriate orthopedic and respiratory care
  • Prognostic Information: Helps anticipate potential complications and outcomes

Understanding Your Test Results

Our genetic specialists provide detailed interpretation of your DLL3 gene test results:

  • Positive Result: Indicates presence of pathogenic DLL3 mutations confirming diagnosis
  • Negative Result: Suggests absence of detectable DLL3 mutations in tested regions
  • Variant of Uncertain Significance: Requires additional family studies for clarification
  • Carrier Status: Identifies individuals with single mutation copy

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Services

We provide comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure accurate and reliable results with a standard turnaround time of 3 to 4 weeks.

Sample Collection and Preparation

This test requires one of the following sample types:

  • Blood sample collected by certified phlebotomist
  • Extracted DNA meeting quality specifications
  • One drop of blood on FTA card for convenient collection

Pre-Test Requirements

Prior to testing, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session with certified genetic counselor
  • Development of detailed family pedigree chart
  • Discussion of testing implications and potential outcomes

Book Your Genetic Test Today

Take the first step toward genetic clarity and personalized medical care. Our team of genetic specialists is ready to assist you with comprehensive testing and counseling services. Contact us today to schedule your DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 NGS Genetic DNA Test.

Call or WhatsApp: +1(267) 388-9828

Our genetic testing services are available through multiple specialties including Dermatology, Genetics, and specialized departments focusing on Osteology, Dermatology, and Immunology Disorders. Trust our expertise in NGS technology for accurate genetic diagnosis and comprehensive patient care.